封面
市场调查报告书
商品编码
1671833

外泌体市场按产品/服务、适应症、用途、製造服务、最终用途和地区划分

Exosomes Market, By Product & Service, By Indication, By Application, By Manufacturing Service, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 120 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球外泌体市场规模估计为 2.221 亿美元,预计 2032 年将达到 12.841 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 28.5%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 2.221亿美元
效能资料 从 2020 年到 2024 年 预测期 2025 至 2032 年
预测期:2025-2032年复合年增长率: 28.50% 2032 年价值预测 12.841亿美元
图。
外泌体市场-IMG1

外泌体是奈米大小的细胞外囊泡,可作为细胞间信使,在细胞之间转移蛋白质、脂质和遗传物质。外泌体由多种类型的细胞自然释放,并携带反映宿主细胞的特定生物分子。由于这种能力,外泌体已成为肿瘤学、神经病学和循环系统等各个应用领域的潜在诊断和治疗工具。预计在预测期内,针对复杂疾病的基于外泌体的治疗和诊断方法的日益普及将推动市场的成长。

市场动态:

全球外泌体市场的成长受到多种因素的推动,例如外泌体科学研究资金的增加、外泌体在疾病管理中的临床应用的增加以及製药公司对利用外泌体优势的兴趣日益浓厚。然而,外泌体分离和表征技术方面的技术挑战以及基于外泌体的程序相关的高成本等因素可能会抑制市场的成长。市场上还有机会可以帮助克服当前的挑战,例如发现基于外泌体的新型疗法以及使用外泌体进行药物输送。此外,人们对外泌体在疫苗开发中的应用越来越感兴趣,这将在预测期内开闢新的途径。

本研究的主要特点

本报告对全球外泌体市场进行了详细分析,并以 2024 年为基准年,给出了预测期(2025-2032 年)的市场规模和年复合成长率(CAGR%)。

它还揭示了各个领域的潜在商机,并解释了该市场有吸引力的投资提案矩阵。

它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。

全球外泌体市场的主要企业是根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行的分析。

研究涉及的主要企业包括赛默飞世尔科技公司 (Thermo Fisher Scientific, Inc.)、Bio-Techne、QIAGEN、Lonza、System Biosciences, LLC、Miltenyi Biotech、NX Pharmagen、Aethlon Medical, Inc.、Creative Medical Technologies Holdings, Inc.、Exopharm、RoosterBio, Inc.、丹纳赫克、丹纳赫。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球外泌体市场报告迎合了该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员可以透过用于分析全球外泌体市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • PORTER 分析
  • 併购情景
  • 产业趋势

4. 2020 年至 2032 年全球外泌体市场(按产品和服务划分)(百万美元)

  • 套件和试剂
  • 抗体
  • 分离、精製及定量套件
  • 其他套件和试剂
  • 装置
  • 服务

5. 全球外泌体市场,按适应症,2020-2032 年(百万美元)

  • 癌症
  • 神经退化性疾病
  • 心血管疾病
  • 感染疾病
  • 其他疾病

6. 全球外泌体市场,依应用划分,2020-2032 年(百万美元)

  • 生物标誌物
  • 疫苗研发
  • 组织再生
  • 药物输送
  • 其他的

7. 2020 年至 2032 年全球外泌体市场(依製造服务划分)(百万美元)

  • 干细胞来源的外泌体
  • 树突细胞衍生的外泌体
  • 其他的

8. 全球外泌体市场,依最终用途,2020-2032 年(百万美元)

  • 学术研究所
  • 製药和生物技术公司
  • 医院和临床实验室
  • 其他的

9. 2020 年至 2032 年全球外泌体市场按地区分類的价值(百万美元)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第十章 竞争格局

  • Thermo Fisher Scientific, Inc.
  • Bio-Techne
  • QIAGEN
  • Lonza
  • System Biosciences, LLC
  • Miltenyi Biotech
  • NX Pharmagen
  • Aethlon Medical, Inc.
  • Creative Medical Technologies Holdings, Inc.
  • Exopharm
  • RoosterBio, Inc.
  • Danaher Corporation
  • Everzom
  • Ciloa
  • Unchained Labs

第 11 章 分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会地图

第 12 章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI7732

The Global Exosomes Market is estimated to be valued at USD 222.1 Mn in 2025 and is expected to reach USD 1,284.1 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 28.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 222.1 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 28.50% 2032 Value Projection: USD 1,284.1 Mn
Figure. Exosomes Market Share (%), By Region, 2025
Exosomes Market - IMG1

Exosomes are nano-sized extracellular vesicles that act as intercellular messengers by transferring proteins, lipids, and genetic materials between cells. They are released naturally by many cell types and carry specific biomolecules reflective of the host cells. Due to this ability, exosomes have emerged as potential diagnostic and therapeutic tools across various application areas such as oncology, neurology, and cardiology. The rising adoption of exosome-based therapies and diagnostics for complex diseases is expected to drive the market growth during the forecast period.

Market Dynamics:

The growth of the global exosomes market is driven by factors such as increasing research funding in exosome science, rising clinical applications of exosomes in disease management, and growing focus of pharmaceutical companies on harnessing exosome benefits. However, factors such as technical challenges in exosome isolation and characterization techniques as well as high costs associated with exosome-based procedures are likely to restrain the market growth. The market also presents opportunities in areas such as discovery of novel exosome-based therapies and use of exosomes for drug delivery that can help in overcoming some of the current challenges. Furthermore, growing interest in exosome applications in vaccine development will open up new avenues during the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global exosomes market and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global exosomes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Bio-Techne, QIAGEN, Lonza, System Biosciences, LLC, Miltenyi Biotech, NX Pharmagen, Aethlon Medical, Inc., Creative Medical Technologies Holdings, Inc., Exopharm, RoosterBio, Inc., Danaher Corporation, Everzom, Ciloa, and Unchained Labs

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global exosomes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosomes market

Market Segmentation

  • By Product & Service Insights (Revenue, USD Mn, 2020 - 2032)
    • Kits & Reagents
    • Antibodies
    • Isolation, Purification, Quantitation Kits
    • Other Kits & Reagents
    • Instruments
    • Services
  • By Indication Insights (Revenue, USD Mn, 2020 - 2032)
    • Cancer
    • Neurodegenerative Diseases
    • Cardiovascular Diseases
    • Infectious Diseases
    • Other Diseases
  • By Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Biomarkers
    • Vaccine Development
    • Tissue Regeneration
    • Drug Delivery
    • Other Applications
  • By Manufacturing Service Insights (Revenue, USD Mn, 2020 - 2032)
    • Stem Cell-Derived Exosome Manufacturing Services
    • Dendritic Cell-Derived Exosome
    • Others
  • By End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Clinical Laboratories
    • Others
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific, Inc.
    • Bio-Techne
    • QIAGEN
    • Lonza
    • System Biosciences, LLC
    • Miltenyi Biotech
    • NX Pharmagen
    • Aethlon Medical, Inc.
    • Creative Medical Technologies Holdings, Inc.
    • Exopharm
    • RoosterBio, Inc.
    • Danaher Corporation
    • Everzom
    • Ciloa
    • Unchained Labs

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Exosomes Market, By Product & Service
    • Global Exosomes Market, By Indication
    • Global Exosomes Market, By Application
    • Global Exosomes Market, By Manufacturing Service
    • Global Exosomes Market, By End User
    • Global Exosomes Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Exosomes Market, By Product & Service, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Antibodies
  • Isolation, Purification, Quantitation Kits
  • Other Kits & Reagents
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Exosomes Market, By Indication, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Neurodegenerative Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Exosomes Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biomarkers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Vaccine Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Tissue Regeneration
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Drug Delivery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Exosomes Market, By Manufacturing Service, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stem Cell-Derived Exosome Manufacturing Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Dendritic Cell-Derived Exosome
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Exosomes Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Hospitals & Clinical Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Exosomes Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Manufacturing Service, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Thermo Fisher Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Techne
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
  • Lonza
  • System Biosciences, LLC
  • Miltenyi Biotech
  • NX Pharmagen
  • Aethlon Medical, Inc.
  • Creative Medical Technologies Holdings, Inc.
  • Exopharm
  • RoosterBio, Inc.
  • Danaher Corporation
  • Everzom
  • Ciloa
  • Unchained Labs

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us